A portfolio of stocks I've been building since September 3 is named Volio Folio. It will eventually hold 52 dividend dogs. Volio is the fifth portfolio I've built (at a one dividend dog per-week pace) since 2014. Five portfolios = V for Volio!

Today I'm reviewing the third of four healthcare stocks striving to be picked to join my Volio folio. This could be the thirteenth pick for Volio!

That healthcare sector includes ten industries all related to testing, diagnosing and treating what ails us. Health industries are: biotechnology; diagnostics & research; drug manufacturers - major and - specialty & generic; healthcare plans; long-term care facilities; medical care; medical devices; medical distribution; medical supplies.

My subject today is a micro-cap medical supplies manufacturer named, Kewaunee Scientific Corp. Their trading ticker symbol is KEQU.

I last reported on Kewaunee Scientific on June 3rd as an industrial sector pick for my Ivy Portfolio. It was not chosen.

Kewaunee Scientific Corp is engaged in the design, manufacture, and installation of laboratory, healthcare, and technical furniture products. The company operates through two segments: Domestic US  and International.

The Domestic US business segment designs manufacture and install scientific and technical furniture, including steel and wood laboratory cabinetry, fume hoods, laminate casework, flexible systems, work surfaces, workstations, workbenches, and computer enclosures.

The International business segment provides facility design, engineering, construction and project management from the planning stage through testing and commissioning of laboratories. The company generates a majority of its revenue from the Domestic US business segment.

The company sells its products primarily through dealers, commissioned agents, and a national distributor, as well as through competitive bids submitted by the company and its subsidiaries in Singapore, India, and China.

Kewaunee Scientific Corporation was founded in 1906 and is headquartered in Statesville, North Carolina.

I use three key data points to gauge dividend-paying equities or funds like Kewaunee Scientific Corp:

(1) Price

(2) Dividends

(3) Returns

Besides those three, several other keys will finally unlock an equity or fund in which to invest, or not.

Those three basic keys, however, best tell whether a company has made, is making, and will make money.

KEQU Price

Kewaunee's price per share closed at $16.25 yesterday. A year ago its price was $27.20. So, in the past year, its price dropped  $10.69, just over 40%.

Assuming Kewaunee's stock trades in a range of $10 to $25 this next year, it's recent $16.25 price could rise by $4.75  to reach $21.00 by late-November, 2020, assuming upward price momentum continues.

KEQU Dividends

Kewaunee's latest declared quarterly dividend was 0.19, paid September 24th.

That $0.19 Q dividend equates to $0.76 annually and yields 4.68% based on yesterday's $16.25 closing price.

KEQU Gains?

Adding the $0.76 annual estimated dividend to my $4.75 estimate of Kewaunee's price upside shows a $5.51 potential gross gain, per share, which will be reduced by any costs to trade these shares.

Say, for costs, we put a little over $1,000.00 today into Kewaunee Scientific Corp at its recent $16.25 price, we'd buy 61 shares of KEQU.

A $10 broker fee paid half at purchase and half at sale could cost us about $0.16 per share.

Subtract that $0.16 brokerage cost from the estimated $5.51 gross estimated gain per share leaves a net gain of $5.35 X 62 shares = $331.70 or a 33% net gain on a $1,007.50 investment.

Therefore, Kewaunee Scientific Corp, whose trading ticker symbol is KEQU shows a possible 33% net gain including a 4.68% dividend yield. It could be more, it could be less.

The above speculation is based on past year performance. The actual results remain to be seen to learn if Kewaunee Scientific Corp is worth your time and money.